Why is DocGo stock sliding today?
DocGo (DCGO) shares fell about 12.7% pre-open to $0.62 after its Q2 2026 results missed expectations. Adjusted loss per share was $0.16 vs $0.10 forecast, revenue was $73.4M vs $75.4M. DocGo cut full-year 2026 adjusted EBITDA guidance to a $17M to $22M loss and agreed to acquire Hicuity Health, largely via debt assumption and new financing.
How this was made
The 30-second read
Why it matters
For traders, the actionable elements are the revised full-year EBITDA loss outlook and the acquisition structure, both of which directly affect valuation, financing risk, and expectations for EBITDA breakeven timing.
Market read
DocGo’s pre-open drop is tied to concrete financial results and forward guidance plus a definitive acquisition with near-term balance-sheet implications, in a risk-off macro tape.
What to watch
The acquisition could be strategically value-accretive, and the market may be over-weighting near-term balance-sheet optics versus longer-term virtual-care scaling; deal terms and integration execution are key.
Background
The article frames the selloff as driven by DocGo’s Q2 earnings miss, a sharp guidance deterioration, and a definitive acquisition of Hicuity Health with assumed debt and additional financing commitments.
Ticker impact
DocGo shares slide ~12.7% pre-open after an earnings miss and a cut to full-year 2026 adjusted EBITDA loss guidance.
Bearish near term, with volatility likely until investors gain confidence in the path to EBITDA breakeven and deal financing terms.
The article cites specific, time-sensitive disclosures: adjusted loss per share and revenue below consensus, a widened full-year EBITDA loss range, and a definitive acquisition agreement involving assumed debt and new financing commitments.
Market effects
Highlights heightened sensitivity of small-cap healthcare services and virtual-care names to guidance cuts and balance-sheet risk.
US risk-off tone (Nasdaq and S&P futures down) likely reinforces selling pressure in high-beta small caps.
Geopolitical escalation risk can spill into global risk appetite, increasing discount rates for growth and unprofitable issuers.
Counterpoint
Excluding migrant revenue, management cites 19% year-over-year growth and a record medical transportation quarter, which could limit long-term damage if investors refocus on operating momentum.
Key entities
- companyDocGo
US-listed healthcare services company whose stock is down pre-open after earnings miss, guidance cut, and a debt-structured acquisition agreement.
- companyHicuity Health
Telemedicine provider DocGo agreed to acquire, with trailing 12-month revenue cited and existing debt assumed as part of the deal.
- investorPerceptive Advisors
Named as providing up to $50 million in new financing commitments for the acquisition.
